Your Notifications
All done, no notifications

Why Sickle Cell Disease Is So Common in Africa: The Malaria-Genetics Connection

Transplants

Published: May 14, 2026

Updated: May 14, 2026

Published: May 14, 2026

Updated: May 14, 2026

Why Sickle Cell Disease Is So Common in Africa: The Malaria-Genetics Connection

Sickle Cell Disease is an inherited blood disorder that affects haemoglobin, the protein inside red blood cells responsible for carrying oxygen throughout the body. Red blood cells can easily pass through blood vessels since they are typically spherical and flexible. 

In sickle cell disease, the cells take on a crescent or "sickle" form and become stiff and sticky. These aberrant cells may obstruct blood flow, resulting in: 

  • Severe pain
  • Anemia
  • Frequent bouts of infection
  • Damage to various organs
  • Strokes

Individuals inherit Sickle Cell Disease from their parents via genes. When both parents transmit the sickle cell gene, their offspring will also inherit this Disease.

Understanding the Genetics of Sickle Cell Disease

It is caused by a mutation in the HBB gene, which helps produce haemoglobin. This mutation leads to the formation of abnormal haemoglobin called Haemoglobin S (HbS).

There are two important genetic possibilities:

1. Sickle Cell Trait (Carrier)

A person inherits:

  • One normal haemoglobin gene
  • One sickle cell gene

This person, known as a "carrier" or someone with sickle cell trait, typically does not have severe symptoms. 

2. Sickle Cell Disease

A person inherits:

  • Two sickle cell genes (one from each parent)

This causes full sickle cell disease. Due to the autosomal recessive inheritance pattern of the illness, a child must receive the sickle cell gene from both parents in order to be affected.

Why Did the Sickle Cell Gene Become Common in Africa?

The main reason is malaria. Africa has been affected by malaria for thousands of years. Malaria had a high death rate before modern medicine, particularly in children.

Researchers found that individuals with sickle cell trait, or having just one sickle cell gene, were more likely to survive in areas where malaria is widespread. Compared to those without the characteristic, they had a lower risk of developing severe malaria.

Because of this protection, carriers were able to reproduce, live longer, and transmit the gene to subsequent generations. In regions where malaria was common, the sickle cell gene grew more prevalent over many generations.

In genetics, this is a perfect example of natural selection. 

Random Genetic Mutation

Thousands of years ago in Africa - One person randomly developed a genetic mutation that made some of their red blood cells slightly sickle-shaped. This was purely accidental not planned by nature or the body.

Sub-Saharan Africa had extremely high malaria rates. Malaria killed millions of people especially children before they could reproduce.

People with ONE copy of the sickle cell gene (carriers/trait):

  • Red blood cells slightly abnormal  
  • Malaria parasite CANNOT survive easily in these cells  
  • Infected cells destroyed faster by the body
  • These people SURVIVED malaria more often

How Sickle Cell Gene Stayed in African Population

When malaria spread across Africa, people without the sickle cell gene were highly vulnerable; many died before they could have children, so their genes slowly disappeared from the population. 

But people who carried the sickle cell gene had a natural shield against malaria; they survived, grew up, had children, and passed that protective gene on. Their children did the same, and their children's children too. 

Repeat this cycle for hundreds of generations over thousands of years, and the sickle cell gene gradually became common across African populations not because anyone planned it, but simply because carriers lived long enough to pass it on, and non-carriers often didn't.

  • Generation 1: Very few people had the gene
  • Generation 10: More people had it
  • Generation 100: Large % of African population carried the gene

Other malaria-prone regions like South Asia and the Mediterranean also developed different genetic adaptations to malaria for the same reason — like G6PD deficiency in Mediterranean populations.

Genotype 

Malaria risk 

Sickle cell disease 

HbA/HbA (normal) 

High

No

HbA/HbS (carrier) 

Low

No

HbS/HbS 

Low

Yes — severe 

How Does the Sickle Cell Trait Protect Against Malaria?

Researchers believe that sickle haemoglobin-containing red blood cells make it difficult for the malaria parasite to survive.

In sickle cell trait carriers:

  • Under stress, red blood cells may sickle a little.
  • The body eliminates contaminated cells more quickly.
  • Malaria parasites are unable to proliferate as efficiently.

Because of this, carriers frequently have some defense against serious malaria infection.

Carriers are still susceptible to malaria despite this protection. It simply lowers the likelihood of serious or deadly illness. 

The Double-Edged Effect of Genetics

The sickle cell trait has historically aided in the survival of certain populations against malaria; however, it has affected people with the condition negatively. 

In a situation in which both parents are carriers of the sickle cell trait, their child can inherit one of the following traits: 25% chance of inheriting SCD (sickle cell disease), 50% chance of being a carrier of the sickle cell trait, or there is a 25% chance of inheriting normal genes (neither SCD nor carrier). 

Therefore, as the sickle cell trait became common amongst the areas affected by malaria, the incidence of children being born with SCD also increased. Very high carrier prevalence continues to exist in many countries in Africa.

The WHO (World Health Organisation) Regional Office for Africa indicates that the carrier prevalence for several countries (e.g., Nigeria, Ghana, Cameroon and Congo) remains at approximately 20 - 30%, whereas some regions of Uganda are exceeding 45%.

Which African Countries Are Most Affected?

Sickle cell disease is especially common in:

  • Nigeria
  • Ghana
  • Uganda
  • Kenya
  • Tanzania
  • Cameroon
  • Democratic Republic of Congo

Nigeria has one of the highest numbers of sickle cell births globally.

Due to the sickle cell trait's historical survival benefit, the disorder is more prevalent in tropical and malaria-prone areas.

Sickle Cell Disease Is Not a Curse

Sickle cell illness is still misdiagnosed in some communities. Some people mistakenly think that poor luck, supernatural attacks, or curses are to blame.

According to science, sickle cell disease is entirely inherited.

Due to genes acquired from both parents, a kid is born with the illness. It is not communicable and cannot be spread by:

  • Food
  • Physical interaction
  • Getting married
  • Sharing clothing
  • Witchcraft

Reducing stigma and discrimination in African communities requires raising awareness and educating the public. 

Why Genetic Testing Matters Before Marriage

Awareness and premarital genetic testing can assist in reducing the prevalence of this disease. In many African nations, couples are encouraged to determine their genotype prior to marriage. The three main genotypes are as follows: 

  • *AA* (the normal genotype), 
  • *AS* (a carrier), and *SS* (a person who has Sickle Cell Disease). 

If both partners are *AS*, then they are at an increased risk for having children with this Disease, so genetic counselling may be of benefit to the couple for providing information about these risks and assisting them in making informed decisions for family planning.

Can Sickle Cell Disease Be Prevented?

Genetically, the disease itself cannot usually be prevented, but with early detection and appropriate treatment, complications and fatalities can be decreased.

Crucial actions consist of:

  • screening of newborns
  • Immunizations
  • Frequent medical examinations
  • Sufficient hydration
  • Preventing infections
  • Availability of drugs such as hydroxyurea

Early diagnosis and better access to healthcare can greatly increase survival and quality of life, according to the WHO. 

The Future of Sickle Cell Care in Africa

There is growing awareness about sickle cell disease across Africa. Many governments, hospitals, NGOs, and advocacy groups are improving:

  • Public education
  • Newborn screening programs
  • Access to treatment
  • Community support

Research into gene therapy and advanced treatments also offers hope for the future. However, access remains limited in many African regions.

Final Thoughts

This disease became common in Africa because of genetics and malaria. The sickle cell trait helped protect generations of people from severe malaria, allowing the gene to survive and spread over time.

While this evolutionary advantage helped many communities survive malaria, it also increased the number of children born with sickle cell disease.

Today, education, genotype testing, early diagnosis, and better healthcare can help African families manage and reduce the burden of this disease. Understanding the genetics behind the condition is an important step toward ending stigma and improving lives.

Frequently Asked Questions

It is common in Africa because of its historical link to malaria. People who carry one sickle cell gene (sickle cell trait) have a natural protection against severe malaria, which allowed them to survive and pass the gene to future generations. Over thousands of years, this made the sickle cell gene increasingly common across malaria-prone regions of Africa.

If both parents carry the sickle cell trait (AS genotype), each pregnancy carries a 25% chance the child will have sickle cell disease (SS), a 50% chance the child will be a carrier (AS), and a 25% chance the child will inherit normal genes (AA). Genetic counselling is strongly recommended for such couples before starting a family.

It cannot currently be prevented through genetics alone, but its impact can be significantly reduced through newborn screening, vaccinations, regular medical check-ups, and medications like hydroxyurea. Premarital genotype testing is strongly encouraged across Africa to help couples make informed family planning decisions. Emerging gene therapy treatments also offer hope for a future cure.

The most reliable way is through a newborn screening test done shortly after birth. If missed, watch for warning signs like unexplained pain, swollen hands and feet, frequent infections, and fatigue. Ask your doctor for a haemoglobin electrophoresis test — this confirms whether your child has the disease, carries the trait, or is completely unaffected.

Salus Active

Confused

Finding too much Information to browse through...talk to our smart SALUS AI to get the precise answers.

Salus

Avail Medical Counseling

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Shagufta Parveen
Author

Shagufta Parveen

Dr. Shagufta Parveen is a medical and scientific content writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad. During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources. Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

Dr. Vishwas
Reviewer

Dr. Vishwas

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, is known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries.

Other Related Blogs

Meet our healthcare experts

Ajay Kaul
Dr. Ajay Kaul

Delhi, India

38 Years of experience

USD50 for Video Consultation

Aashish Chaudhry
Dr. Aashish Chaudhry

Delhi, India

16 Years of experience

USD32 for Video Consultation

Puneet Girdhar
Dr. Puneet Girdhar

Delhi, India

18 Years of experience

USD50 for Video Consultation

Erdal Karaoz
Dr. Erdal Karaoz

Istanbul, Turkey

34 Years of experience

USD240 for Video Consultation

Top Hospitals Partner

Other Resources